Anaplastic meningioma: Progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence

Neuropathology

Volumn 30, Issue 3, 2010, Pages 279-287

  Bollag, Roni J ^a   Vender, John R ^a   Sharma, Suash ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Anaplastic; Atypical; Chordoid; CNS neoplasms; Meningioma; Tumor progression

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN;

ADULT; ARTICLE; BRAIN EDEMA; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; MITOSIS RATE; MORPHOTYPE; NECROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; VISUAL DISORDER;

CHOROID PLEXUS NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 77952940931     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2009.01060.x     Document Type: Article

References (25)

1. Louis DN, Ohgaki H, Wiestler OD et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 2007 114 : 97 109.
2. Perry A, Louis DN, Scheithauer BW, Budka H, von Diemling A. Meningiomas. In : Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn.
3. Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet 2004 363 : 1535 1543.
4. Prayson RA. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. Am J Clin Pathol 1996 105 : 719 726.
5. Krayenbühl N, Pravdenkova S, Al-Mefty O. De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome. Neurosurgery 2007 61 : 495 503 discussion 503 504.
6. Dziuk TW, Woo S, Butler EB et al. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 1998 37 : 177 188.
7. Hug EB, Devries A, Thornton AF et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 2000 48 : 151 160.
8. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 1993 33 : 955 963.
9. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999 85 : 2046 2056.
10. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997 21 : 1455 1465.
11. Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 2005 57 : 538 550 discussion 538 550.
12. Ketter R, Rahnenführer J, Henn W et al. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas. Neurosurgery 2008 62 : 61 69 discussion 69-70.
13. Ko KW, Nam DH, Kong DS, Lee JI, Park K, Kim JH. Relationship between malignant subtypes of meningioma and clinical outcome. J Clin Neurosci 2007 14 : 747 753.
14. Liu Y, Liu M, Li F, Wu C, Zhu S. Malignant meningiomas: a retrospective study of 22 cases. Bull Cancer 2007 94 : E27 E31.
15. Maier H, Ofner D, Hittmair A, Kitz K, Budka H. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992 77 : 616 623.
16. Moradi A, Semnani V, Djam H et al. Pathodiagnostic parameters for meningioma grading. J Clin Neurosci 2008 15 : 1370 1375.
17. Korshunov A, Shishkina L, Golanov A. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome. Int J Cancer 2003 104 : 728 734.
18. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 2004 101 : 210 218.
19. Jääskeläinen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 1986 25 : 233 242.
20. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol (Berl) 2005 109 : 93 108.
21. Kleihues P, Burger PC, Aldape KD et al. WHO classification of tumours of the central nervous system. In : Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours, 4th edn.
22. Ludwin SK, Conley FK. Malignant meningioma metastasizing through the cerebrospinal pathways. J Neurol Neurosurg Psychiatry 1975 38 : 136 142.
23. Ketter R, Urbschat S, Henn W et al. Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas. Int J Cancer 2007 121 : 1473 1480.
24. Okamoto H, Li J, Vortmeyer AO et al. Comparative proteomic profiles of meningioma subtypes. Cancer Res 2006 66 : 10199 10204.
25. Pasquier D, Bijmolt S, Veninga T et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2008 71 : 1388 1393.